Kenya urged to adopt CAB-LA for HIV prevention
Kenya has been called upon, alongside other countries, to consider adopting the new guidelines by World Health Organization (WHO) for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis
Read on